The name on the proposed medicine

Ask about the actual product

The Food and Drug Administration (FDA) checks evidence about a medicine for a particular health problem.

Ozempic and Wegovy contain a drug called semaglutide. Among the US approvals checked on September 26, 2026, Ozempic treats type 2 diabetes; Wegovy helps manage weight.

Mounjaro and Zepbound contain tirzepatide, another drug ingredient. The US approvals checked on September 26, 2026 include treating type 2 diabetes with Mounjaro and managing weight with Zepbound.

Ask the person treating you which brand and form they mean, and what it would treat. Keep the ingredient name beside the brand name.

What “compounded” adds to the question

Here, compounding means a doctor or pharmacist prepares medicine for a particular need rather than supplying a finished factory product.

As of September 26, 2026, a drug made this way carries no FDA approval.

A made-to-order medicine goes on sale without an FDA check of its safety, how well it works or the quality of its preparation.

One reason the FDA describes for compounding is a patient’s medical need beyond what an approved drug can meet.

The FDA also describes compounding when you cannot obtain the approved medicine as a ready-made product.

Ask why the proposed preparation is needed for you and which pharmacy will prepare it. Request an explanation that goes beyond a lower headline price.

A local empty shelf is a different issue

In the September 26, 2026 record, neither semaglutide injection nor tirzepatide appears on the FDA’s national shortage list.

An empty shelf nearby does not put a drug on that national list.

Ask why this exact medicine can be made. Put that question to whoever writes your prescription, then to the pharmacy as well. A past shortage is not an answer about a new prescription.

A research label does not supply care

Watch for the words “for research purposes” on a weight-drug offer. Another label says “not for human consumption”, meaning people must not consume it. The FDA warns against these products when sold for people to use: their quality is unknown and they may harm health (checked September 26, 2026).

Retatrutide and cagrilintide are drug ingredients without approval to treat any illness. The FDA’s position checked on September 26, 2026 is that federal law bars both ingredients from medicine made to order by a doctor or pharmacy.

If a name is unfamiliar, write it down exactly. Ask a doctor or other health professional to explain whether it is approved and what rules apply before treating a sales page as a care plan.